Curing cancer with Cannabidiol?
- CANNABIS OIL, NEWS
- April 24, 2013

Indiana State Sen. Mike Bohacek is preparing 2027 legislation that would legalize medical marijuana, citing shifting federal policy and growing openness from Gov. Mike Braun. The proposal follows the Trump administration’s move to reclassify state-licensed medical marijuana as a less-restricted Schedule III drug, a change that recognizes its medical use under federal law. Bohacek’s measure
READ MORE
The Trump administration’s decision to reclassify medical marijuana from Schedule I to Schedule III could quietly remake the Midwest cannabis landscape, even as prohibition holds firm in states like Wisconsin. The federal move leaves recreational marijuana untouched but opens the door for medical operators to access tax deductions, federal credits, and mainstream banking services that
READ MORE
Federal drug policy took a notable shift on April 23, when Acting U.S. Attorney General Todd Blanche ordered state-licensed medical marijuana moved from Schedule I to Schedule III, a category reserved for substances with “moderate to low” dependence risk. The change acknowledges growing public support for medical cannabis but stops short of altering federal rules
READ MORE
After nearly five years of legislative approval and extensive litigation, Alabama’s medical cannabis program is finally approaching launch. According to Alabama.com, the first biomass was delivered to processors on April 10, with dispensaries expected to open in early to mid-May. Alabama’s program prohibits smokable forms, restricting products to tablets, tinctures, patches, oils, and peach-flavored gummies. The
READ MORE